BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

882 related articles for article (PubMed ID: 32079712)

  • 1. Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients.
    Crivellaro C; Landoni C; Elisei F; Buda A; Bonacina M; Grassi T; Monaco L; Giuliani D; Gotuzzo I; Magni S; Di Martino G; Delle Marchette M; Guerra L; Landoni F; Fruscio R; Messa C; De Bernardi E
    Int J Gynecol Cancer; 2020 Mar; 30(3):378-382. PubMed ID: 32079712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness and potential pitfalls of pre-operative PET-CT in patients with endometrial cancer undergoing one- and two-step sentinel lymph node mapping: Do negative findings on PET-CT negativity really indicate node negativity?
    Kim YN; Lee D; Cha J; Kang WJ; Lee YJ; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
    Gynecol Oncol; 2022 Sep; 166(3):438-443. PubMed ID: 35907682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph node mapping in endometrial cancer: performance of hysteroscopic injection of tracers.
    Martinelli F; Ditto A; Bogani G; Leone Roberti Maggiore U; Signorelli M; Chiappa V; Raspagliesi F
    Int J Gynecol Cancer; 2020 Mar; 30(3):332-338. PubMed ID: 31911536
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Mayoral M; Paredes P; Domènech B; Fusté P; Vidal-Sicart S; Tapias A; Torné A; Pahisa J; Ordi J; Pons F; Lomeña F
    Rev Esp Med Nucl Imagen Mol; 2017; 36(1):20-26. PubMed ID: 27667001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementary role of 18F-FDG PET/CT for sentinel lymph node algorithm in endometrial cancer with high-risk factors for lymphatic metastasis.
    Taşkin S; Varli B; Ersöz CC; Altin D; Soydal Ç; Ortaç F
    Nucl Med Commun; 2020 Apr; 41(4):389-394. PubMed ID: 31939903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combination of preoperative PET/CT and sentinel lymph node biopsy in the surgical management of early-stage cervical cancer.
    Papadia A; Gasparri ML; Genoud S; Bernd K; Mueller MD
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2275-2281. PubMed ID: 28669052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Sentinel Lymph Node Biopsy in Endometrial Cancer Patients: A Prospective Study.
    Palaia I; Di Donato V; Musella A; Di Pinto A; Santangelo G; Petriglia G; Benedetti Panici P
    J Invest Surg; 2021 Jun; 34(6):672-676. PubMed ID: 31647346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel Lymph Node Mapping in Endometrial Cancer: An Update.
    Khoury-Collado F; St Clair C; Abu-Rustum NR
    Oncologist; 2016 Apr; 21(4):461-6. PubMed ID: 26961924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
    Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
    Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.
    Rossi EC; Kowalski LD; Scalici J; Cantrell L; Schuler K; Hanna RK; Method M; Ade M; Ivanova A; Boggess JF
    Lancet Oncol; 2017 Mar; 18(3):384-392. PubMed ID: 28159465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staging of High-Risk Endometrial Cancer With PET/CT and Sentinel Lymph Node Mapping.
    Signorelli M; Crivellaro C; Buda A; Guerra L; Fruscio R; Elisei F; Dolci C; Cuzzocrea M; Milani R; Messa C
    Clin Nucl Med; 2015 Oct; 40(10):780-5. PubMed ID: 26053711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Combination of Preoperative Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Sentinel Lymph Node Mapping in the Surgical Management of Endometrioid Endometrial Cancer.
    Bese T; Sal V; Demirkiran F; Kahramanoglu I; Tokgozoglu N; Ilvan S; Aydin O; Hallac M; Vatankulu B; Demirayak G; Turan H; Arvas M
    Int J Gynecol Cancer; 2016 Sep; 26(7):1228-38. PubMed ID: 27643647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma?
    Schaarschmidt BM; Grueneisen J; Stebner V; Klode J; Stoffels I; Umutlu L; Schadendorf D; Heusch P; Antoch G; Pöppel TD
    Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2093-2102. PubMed ID: 29876618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative PET/CT does not accurately detect extrauterine disease in patients with newly diagnosed high-risk endometrial cancer: A prospective study.
    Stewart KI; Chasen B; Erwin W; Fleming N; Westin SN; Dioun S; Frumovitz M; Ramirez PT; Lu KH; Wong F; Aloia TA; Soliman PT
    Cancer; 2019 Oct; 125(19):3347-3353. PubMed ID: 31225906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node mapping in early-stage cervical cancer - A national prospective multicenter study (SENTIREC trial).
    Sponholtz SE; Mogensen O; Hildebrandt MG; Schledermann D; Parner E; Markauskas A; Frøding LP; Fuglsang K; Vilstrup MH; Bjørnholt SM; Jensen PT
    Gynecol Oncol; 2021 Sep; 162(3):546-554. PubMed ID: 34226018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technetium-99m-indocyanine green versus technetium-99m-methylene blue for sentinel lymph node biopsy in early-stage endometrial cancer.
    Cabrera S; Bebia V; Franco-Camps S; Forcada C; Villasboas-Rosciolesi D; Navales I; Pérez-Benavente A; Gil-Moreno A
    Int J Gynecol Cancer; 2020 Mar; 30(3):311-317. PubMed ID: 31992599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of outcomes between the one-step and two-step sentinel lymph node mapping techniques in endometrial cancer.
    Kim YN; Eoh KJ; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
    Int J Gynecol Cancer; 2020 Mar; 30(3):318-324. PubMed ID: 31992601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic accuracy of fluorodeoxyglucose-positron emission tomography/computed tomography and sentinel node biopsy in the prediction of pelvic lymph node metastasis in patients with endometrial cancer: A retrospective observational study.
    Tanaka T; Terai Y; Yamamoto K; Yamada T; Ohmichi M
    Medicine (Baltimore); 2018 Sep; 97(38):e12522. PubMed ID: 30235772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node biopsy in early stage endometrial cancer: a Turkish gynecologic oncology group study (TRSGO-SLN-001).
    Taşkın S; Altin D; Vatansever D; Tokgozoglu N; Karabük E; Turan H; Takmaz Ö; Kahramanoglu I; Naki MM; Güngör M; Köse F; Ortac F; Arvas M; Ayhan A; Taskiran C
    Int J Gynecol Cancer; 2020 Mar; 30(3):299-304. PubMed ID: 31857440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Utility of Sentinel Lymph Node Mapping in High-Grade Endometrial Cancer.
    Tanner EJ; Ojalvo L; Stone RL; Levinson K; Temkin SM; Murdock T; Vang R; Sinno AK; Fader AN
    Int J Gynecol Cancer; 2017 Sep; 27(7):1416-1421. PubMed ID: 30814241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.